These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20638312)

  • 21. Pitfalls in newborn screening.
    Crombez E; Koch R; Cederbaum S
    J Pediatr; 2005 Jul; 147(1):119-20. PubMed ID: 16027710
    [No Abstract]   [Full Text] [Related]  

  • 22. Neonatal screening for inborn errors of metabolism.
    Hardelid P; Dezateux C
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2176. PubMed ID: 15978919
    [No Abstract]   [Full Text] [Related]  

  • 23. Newborn screening for inborn errors of metabolism in Beijing, China: 22 years of experience.
    Tu WJ; Cai J; Shi XD
    J Med Screen; 2011; 18(4):213-4. PubMed ID: 22184735
    [No Abstract]   [Full Text] [Related]  

  • 24. Newborn screening for genetic disorders.
    Fernhoff PM
    Pediatr Clin North Am; 2009 Jun; 56(3):505-13, Table of Contents. PubMed ID: 19501689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Screening of newborn infants for inborn errors of metabolism].
    Halvorsen S; Skjelkvåle L
    Tidsskr Nor Laegeforen; 1970 Jan; 90(2):233-5. PubMed ID: 5430194
    [No Abstract]   [Full Text] [Related]  

  • 26. [Beginnings, evolution and current situation of the Newborn Screening Programs in Spain.].
    Marín Soria JL; González de Aledo Castillo JM; Argudo Ramírez A; López Galera RM; Pajares García S; Ribes Rubió A; García Villoria J; Yahyaoui Macías R; Álvarez Ríos AI; Melguizo Madrid E; González Irazabal Y; Hernández de Abajo G; Prieto García B; Cardo González L; Martínez Morillo E; Robles Bauza J; Bauçà Rosselló JM; Pérez Esteban G; Díaz-Flores Estevez F; Pérez Mangas E; Cañadas Garzó V; Muñoz Boyero AC; Redondo Cardeña PA; Bueno Llarena MJ; Sánchez Alarcon J; Castiñeiras Ramos D; Cocho de Juan JÁ; Colón Mejeras C; Blanco Soto P; Cambra Conejero A; Fernández Ruano ML; Ortiz Temprado A; Egea Mellado JM; González Gallego I; Juan Fita MJ; Espada Saenz-Torre M; Rausell Felix D; Marcos Tomás JV; Ruiz Aja S; Delgado Pecellín C; Bóveda Fontán MD
    Rev Esp Salud Publica; 2021 Feb; 95():. PubMed ID: 33619242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mandatory versus voluntary consent for newborn screening?
    Ross LF
    Kennedy Inst Ethics J; 2010 Dec; 20(4):299-328. PubMed ID: 21338027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Universal newborn screening and adverse medical outcomes: a historical note.
    Brosco JP; Seider MI; Dunn AC
    Ment Retard Dev Disabil Res Rev; 2006; 12(4):262-9. PubMed ID: 17183576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fifty years of neonatal screening for congenital diseases in Spain].
    Couce ML
    An Pediatr (Engl Ed); 2019 Apr; 90(4):205-206. PubMed ID: 30583992
    [No Abstract]   [Full Text] [Related]  

  • 30. Newborn screening report sparks debate in USA.
    Black H
    Lancet; 2005 Apr 23-29; 365(9469):1453-4. PubMed ID: 15856541
    [No Abstract]   [Full Text] [Related]  

  • 31. [Half a century of newborn screening in Spain: Evolution of ethical, legal and social issues (ELSIs). Part III, social issues.].
    Labrador Cañadas MV; Pàmpols Ros T; Dulín Íñiguez E; Pérez Aytés A; García Sagredo JM; Díaz de Bustamante A; Martín Arribas C; García López FJ; Nicolás Jiménez P
    Rev Esp Salud Publica; 2021 Jan; 95():. PubMed ID: 33496273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The successful "Guthrie test" celebrates its 10th birthday in Brazil!
    Lopes ME
    Cien Saude Colet; 2011; 16 Suppl 1():716-7. PubMed ID: 21528612
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of other inborn errors of metabolism in hyperphenylalaninemic babies picked up on narrow-spectrum screening programs.
    Unal O; Oztürk-Hişmi B; Coşkun T; Tokatlı A; Dursun A; Sivri HS
    Turk J Pediatr; 2012; 54(4):409-12. PubMed ID: 23692723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parental understanding and attitudes towards neonatal biochemical screening.
    Polichroniadis M
    Midwives Chron; 1989 Feb; 102(1213):42-3. PubMed ID: 2704314
    [No Abstract]   [Full Text] [Related]  

  • 35. The National Institute of Child Health and Human Development and phenylketonuria.
    Alexander D
    Pediatrics; 2003 Dec; 112(6 Pt 2):1514-5. PubMed ID: 14654655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded newborn screening using tandem mass spectrometry.
    Fearing MK; Levy HL
    Adv Pediatr; 2003; 50():81-111. PubMed ID: 14626484
    [No Abstract]   [Full Text] [Related]  

  • 37. [Screening for congenital metabolic disorders].
    Knapp A; Machill G
    Kinderarztl Prax; 1974 Jun; 42(6):270-7. PubMed ID: 4610264
    [No Abstract]   [Full Text] [Related]  

  • 38. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing.
    Chace DH; Kalas TA
    Clin Biochem; 2005 Apr; 38(4):296-309. PubMed ID: 15766731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [After PKU and hypothyroidism, what other screening?].
    Frézal J; Briard ML; Saudubray JM
    J Genet Hum; 1981 Mar; 29(1):47-57. PubMed ID: 7334341
    [No Abstract]   [Full Text] [Related]  

  • 40. Inherited metabolic disorders: from the newborn to the mother and beyond.
    Levy HL
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():119-20. PubMed ID: 11400747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.